dehydroepiandrosterone has been researched along with Urinary Bladder, Overactive in 1 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Urinary Bladder, Overactive: Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matarazzo, MG | 1 |
| Sarpietro, G | 1 |
| Fiorito, D | 1 |
| Di Pasqua, S | 1 |
| Ingrassano, S | 1 |
| Panella, MM | 1 |
| Cianci, A | 1 |
| Caruso, S | 1 |
1 other study available for dehydroepiandrosterone and Urinary Bladder, Overactive
| Article | Year |
|---|---|
Intravaginal 6.5 mg prasterone administration in postmenopausal women with overactive bladder syndrome: A pilot study.
Topics: Administration, Intravaginal; Atrophy; Dehydroepiandrosterone; Female; Humans; Pilot Projects; Postm | 2021 |